Forefront Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-379
Closed -$293K 52
2024
Q4
$293K Buy
+379
New +$314K 0.27% 42

Other funds holding LLY

Forefront Wealth Management's LLY Position: Q1 2025 in Review

Forefront Wealth Management sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 379 shares — an estimated $293K sold.

Forefront Wealth Management first reported a position in LLY in Q4 2024 and held it in 1 quarter. The position peaked at $293K in Q4 2024. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Forefront Wealth Management reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • Forefront Wealth Management sold 379 Eli Lilly shares in Q1 2025, an estimated $293K.
  • Forefront Wealth Management first reported a position in Eli Lilly in Q4 2024 and held it in 1 quarter.
  • Forefront Wealth Management's Eli Lilly position peaked at $293K in Q4 2024.
  • 3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Forefront Wealth Management's 13F filing for Q1 2025, filed 17 Apr 2025.